Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.
Fiche publication
Date publication
mai 2018
Journal
European journal of cancer (Oxford, England : 1990)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BEDENNE Laurent, Pr BOUCHE Olivier, Pr LEPAGE Côme
Tous les auteurs :
Aparicio T, Ducreux M, Faroux R, Barbier E, Manfredi S, Lecomte T, Etienne PL, Bedenne L, Bennouna J, Phelip JM, François E, Michel P, Legoux JL, Gasmi M, Breysacher G, Rougier P, De Gramont A, Lepage C, Bouché O, Seitz JF,
Lien Pubmed
Résumé
Previous studies showed that high and low body mass index (BMI) was associated with worse prognosis in early-stage colorectal cancer (CRC), and low BMI was associated with worse prognosis in metastatic CRC (mCRC). We aimed to assess efficacy outcomes according to BMI.
Mots clés
Bevacizumab, Colorectal cancer, Overweight, Pooled analysis, Prognostic factor
Référence
Eur. J. Cancer. 2018 May 25;98:1-9